Nationale-Nederlanden Powszechne Towarzystwo Emerytalne’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-23,920
Closed -$4.44M 47
2025
Q2
$4.44M Buy
+23,920
New +$4.45M 0.52% 38
2024
Q4
Sell
-129,008
Closed -$25.5M 53
2024
Q3
$25.5M Buy
+129,008
New +$24.1M 3.54% 12
2023
Q4
Sell
-114,844
Closed -$17.1M 32
2023
Q3
$17.1M Hold
114,844
5.4% 10
2023
Q2
$15.5M Buy
114,844
+69,199
+152% +$10.1M 4.49% 11
2023
Q1
$7.27M Sell
45,645
-35,413
-44% -$5.41M 2.57% 18
2022
Q4
$13.1M Buy
81,058
+2,362
+3% +$362K 5.69% 7
2022
Q3
$10.6M Buy
+78,696
New +$11.3M 4.98% 9

Other funds holding ABBV

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's ABBV Position: Q3 2025 in Review

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 23,920 shares — an estimated $4.44M sold.

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in ABBV in Q3 2022 and held it in 7 quarters. The position peaked at $25.5M in Q3 2024. 3,910 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne sold 23,920 AbbVie shares in Q3 2025, an estimated $4.44M.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne first reported a position in AbbVie in Q3 2022 and held it in 7 quarters.
  • Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's AbbVie position peaked at $25.5M in Q3 2024.
  • 3,910 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Nationale-Nederlanden Powszechne Towarzystwo Emerytalne's 13F filing for Q3 2025, filed 12 Nov 2025.